Alarming decrease in patient survival among HCV-infected liver transplant recipients

被引：0
|
作者：
Berenguer, M
Prieto, M
Aguilera, V
Nicolas, D
Carrasco, D
Rayon, M
Mir, J
Berenguer, J
机构：
[1] Hosp La Fe, Serv Hepatogastroenterol, Valencia, Spain
[2] Hosp La Fe, Histopathol Serv, Valencia, Spain
[3] Hosp La Fe, Liver Transplantat & Surg Unit, Valencia, Spain
来源：
JOURNAL OF HEPATOLOGY | 2001年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：32 / 33
页数：2
相关论文
共 50 条
  • [31] CLINICAL, HISTOLOGICAL AND HEMODINAMIC OUTCOMES IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS TREATED WITH PEGILATED INTERFERON PLUS RIBAVIRIN
    Carrion, J. A.
    Crespo, G.
    Miquel, R.
    Garcia-Pagan, J. C.
    Bosch, J.
    Navasa, M.
    Forns, X.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S170 - S171
  • [32] Prediction of significant fibrosis in HCV-infected liver transplant recipients by artificial neural network analysis of clinical factors
    Piscaglia, F.
    Cucchetti, A.
    Benlloch, S.
    Vivarelli, M.
    Camaggi, V.
    Berenguer, J.
    Bolondi, L.
    Pinna, A. D.
    Berenguer, M.
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S66 - S66
  • [33] Transplanting HCV-Infected Kidneys into Uninfected Recipients
    Martins, Paulo N.
    Movahedi, Babak
    Bozorgzadeh, Adel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (11): : 1104 - 1105
  • [34] Significant improvement in the outcome of HCV-infected transplant recipients following the implementation of simple measures
    Berenguer, M
    Aguilera, V
    Prieto, M
    San Juan, F
    Benlloch, S
    Rayón, JM
    Berenguer, J
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 : 45 - 45
  • [35] Hepatic stellate cells: early activation predicts fibrosis in HCV-infected transplant recipients
    Carol Lovegrove
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 (12): : 558 - 559
  • [36] Is Liver Biopsy Still Necessary in Evaluating HCV-infected Kidney Transplant Candidate?
    Cottone, Claudia
    Calmet, Fernando H.
    Martin, Paul
    Bhamidimarri, Kalyan R.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S573 - S573
  • [37] Stability of liver fibrosis among HCV-infected injection drug users
    Mehta, Shruti H.
    Kirk, Gregory D.
    Astemborski, Jacquie
    Sulkowski, Mark S.
    Afdhal, Nezam H.
    Thomas, David L.
    [J]. ANTIVIRAL THERAPY, 2012, 17 (05) : 813 - 821
  • [38] Effect of HIV on Liver Fibrosis Among HCV-Infected African Americans
    Silver, D.
    Karnik, G.
    Osinusi, A.
    Silk, R.
    Stabinski, L.
    Doonquah, L.
    Henn, S.
    Teferi, G.
    Masur, H.
    Kottilil, S.
    Fishbein, D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (09) : 1280 - 1283
  • [39] miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation
    Bulfoni, Michela
    Pravisani, Riccardo
    Dalla, Emiliano
    Cesselli, Daniela
    Hidaka, Masaaki
    Di Loreto, Carla
    Eguchi, Susumu
    Baccarani, Umberto
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (08) : 4992 - 5000
  • [40] Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients
    Goldberg, David S.
    Abt, Peter L.
    Blumberg, Emily A.
    Van Deerlin, Vivianna M.
    Levine, Matthew
    Reddy, K. Rajender
    Bloom, Roy D.
    Nazarian, Susanna M.
    Sawinski, Deirdre
    Porrett, Paige
    Naji, Ali
    Hasz, Richard
    Suplee, Lawrence
    Trofe-Clark, Jennifer
    Sicilia, Anna
    McCauley, Maureen
    Farooqi, Midhat
    Gentile, Caren
    Smith, Jennifer
    Reese, Peter P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (24): : 2394 - 2396
12345